Andrew Lloyd ALA

Account no longer active, see pinned tweet👇

International PR group | #biotech #medtech 💉 #electronics #photonics 🛰️ #startups #VC

[Andrew Lloyd ALA @ALA_Group]

🚨 Due to the recent changes to this platform, we're suspending activities on X and moving to BlueSky!

Follow us on @BlueSky for the latest news from innovative startups in biotech, medtech, photonics, deeptech and more👇
https://t.co/8kAtHNTeM9

[Andrew Lloyd ALA @ALA_Group]

[ALA Client in the News] Shankar Sankaran, Director Analytical at SK pharmteco, is featured in @PMPSmag's latest issue discussing the risks of extractables & leachables and how collaborations can help mitigate them🔬

Full article on pages 16-18 👇🔗https://t.co/zmBakIGjwp

[Andrew Lloyd ALA @ALA_Group]

💥 [ALA client news] @MyKayentis enlists experts in oncology, neurodegenerative & metabolic disorders to form scientific advisory board

https://t.co/zDh8VYK11f

#clinicaltrials #oncology #raredisease #neuroscience #cardiology #metabolicdisorders #eCOA #biotech #pharma #medtech

[Andrew Lloyd ALA @ALA_Group]

At-home ECGs will detect early heart issues and save thousands, say doctors

https://t.co/eqpB3m1eIK

#ECG #Cardiovascular #HealthTech

[Andrew Lloyd ALA @ALA_Group]

💥 [ALA client news] Accure Therapeutics partner Oculis reached positive phase 2 results for lead neuroprotective therapy

👉 https://t.co/0PXN73ekde

#CNS #ophthalmology #neurology #neuroscience #ClinicalTrials

[Andrew Lloyd ALA @ALA_Group]

💥Novadip appoints Drew Trivisonno to the board of directors to drive financial and business development

https://t.co/g9jbfKcSwq

#Appointment #Finance #RegenerativeMedicine #Orthopedics #Startups

[Andrew Lloyd ALA @ALA_Group]

🩻 Whether AI can assist in cancer detection has been subject to much debate, but now a real-world test with almost 200 radiologists shows that the technology can improve success rates - @stokel for @newscientist

https://t.co/Im2NSnfOua

#AI #radiology #breastcancer #oncology

[Andrew Lloyd ALA @ALA_Group]

@TechReview has unveiled its definitive list of 10 Breakthrough Technologies for 2025, featuring groundbreaking long-acting #HIV prevention medications and cutting-edge fast learning robots.

Read the full article👇
https://t.co/dbvXRTqHdQ

#biotech #robotics

[Andrew Lloyd ALA @ALA_Group]

Investors optimistic about continued biotech and medtech IPO resurgence in 2025💪

https://t.co/D3w9Cu6DOZ

#biotech #medtech

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] BiPER Therapeutics raises €800,000 in bridge funding to advance its first-in-class BiP-inhibitor for gastrointestinal cancers to clinical trials

👉 https://t.co/qC57VaApBv

#gastriccancer
@Mehdical @wiseed @questforhealth

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] @pdc_line Pharma presents primary clinical results from phase I/II trial on PDC*lung01 cancer vaccine at ESMO-IO 2024

👉 https://t.co/tC5iNaVyBk

#cancervaccine @myESMO #ESMOImmuno24 @EricHalioua

[Andrew Lloyd ALA @ALA_Group]

🚨 We are happy to announce that we’ve moved to our new home at @Future4care ! 🏢💫

We’re excited for what’s to come as we continue to grow and deliver exceptional #PRservices to our #deeptech clients. 🤝✨

Watch the video below for a quick tour of our new office! 🎥👇

[Andrew Lloyd ALA @ALA_Group]

🚀🌊 @NASA is testing cellphone-sized underwater robots to explore distant ocean worlds like Europa & Enceladus. The mini bots could help unlock the secrets of alien oceans

Full story https://t.co/snkniuuPly

@SPACEdotcom @skuthunur #Space

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] Orikine Bio secures €800k in innovation research #funding to advance groundbreaking #autoimmune disease therapy

👉 https://t.co/Q6DgbavfkM

#autoimmunediseases #inflammatorydiseases #drugdiscovery #cytokines

[Andrew Lloyd ALA @ALA_Group]

🌌 Where will space exploration take us in the next 50 years? 🚀

Watch this @BBCIdeas video which delves into how some possibilities, like day trips to the moon and space elevators, may be closer than we think!

🔗 https://t.co/IJZ2B9Me92

#SpaceExploration #SpaceTech

[Andrew Lloyd ALA @ALA_Group]

Eight NHS cancer centres are joining dozens of hospitals around the world to find patients who had extraordinary responses to cancer treatment and lived much longer than expected - @iansample for @guardian

https://t.co/u9VOOVXOYk

#CancerResearch

[Andrew Lloyd ALA @ALA_Group]

Novadip Receives @US_FDA IND Approval for NVDX3 Phase 2b/3 Trial in Cervical Spine Fusion 🚀

🏥 NVDX3 could replace bone grafts, offering better fusion and recovery for patients with complex conditions.

🔗 https://t.co/zeRSvqqFKY

#Innovation #SpineSurgery

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] BiocSol secures €5.2M seed funding to transform sustainable cropprotection with next generation microbial-based solutions

https://t.co/5yzuKc7g4L

#agritech #funding #innovation #agriculture #cropcare #sustainability @VIVES_Fund

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] Scintil Photonics names Matt Crowley as CEO, founder Sylvie Menezo will continue heading technology developments and customer partnerships

https://t.co/krJsj0gwET

#photonics #telecom #innovation #AI #supercomputing #PICs #datacom #siliconphotonics #grenoble

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] PLL Therapeutics obtains authorization to start phase I/II trial in Australia for patients with Amyotrophic Lateral Sclerosis (ALS)

https://t.co/2WTrJqTSjH

#ALS #biotech #diagnostics #autoimmune #microbiome #neurodegenerative #clinicaltrials